Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.

[1]  P. Mital,et al.  Idiopathic hypereosinophilic syndrome. , 2016, The Journal of the Association of Physicians of India.

[2]  Yan Wu,et al.  Glycyrrhizin protects brain against ischemia–reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway , 2014, Brain Research.

[3]  H. Bliddal,et al.  Balance between activating NKG2D, DNAM‐1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts , 2014, Immunology.

[4]  D. Kass,et al.  Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy , 2014, The Journal of experimental medicine.

[5]  M. Barrier,et al.  Natural Killer Cells Induce Eosinophil Activation and Apoptosis , 2014, PloS one.

[6]  M. Johansson,et al.  Activation states of blood eosinophils in asthma , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  Jun Yu,et al.  Increased expression of IL17A in human gastric cancer and its potential roles in gastric carcinogenesis , 2014, Tumor Biology.

[8]  N. Rose,et al.  Fatal Eosinophilic Myocarditis Develops in the Absence of IFN-γ and IL-17A , 2013, The Journal of Immunology.

[9]  W. Murphy,et al.  Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses. , 2013, Blood.

[10]  K. Fujiu,et al.  Contributions of cardiomyocyte–cardiac fibroblast–immune cell interactions in heart failure development , 2013, Basic Research in Cardiology.

[11]  B. Huston,et al.  Death due to eosinophilic necrotizing myocarditis despite steroid treatment. , 2013, The American journal of forensic medicine and pathology.

[12]  D. Čiháková,et al.  Control of inflammatory heart disease by CD4+ T cells , 2013, Annals of the New York Academy of Sciences.

[13]  Rahul C. Deo,et al.  Type 2 Innate Signals Stimulate Fibro/Adipogenic Progenitors to Facilitate Muscle Regeneration , 2013, Cell.

[14]  Xiaofen Pan,et al.  IL-22 exacerbates the severity of CVB3-induced acute viral myocarditis in IL-17A-deficient mice. , 2013, Molecular medicine reports.

[15]  E. Israel,et al.  Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma , 2013, Science Translational Medicine.

[16]  N. Rose,et al.  Macrophage diversity in cardiac inflammation: a review. , 2012, Immunobiology.

[17]  W. Mitzner,et al.  IL-33 Independently Induces Eosinophilic Pericarditis and Cardiac Dilation: ST2 Improves Cardiac Function , 2012, Circulation. Heart failure.

[18]  Eric Vivier,et al.  Targeting natural killer cells and natural killer T cells in cancer , 2012, Nature Reviews Immunology.

[19]  N. Rose,et al.  Macrophages participate in IL‐17‐mediated inflammation , 2012, European journal of immunology.

[20]  Sheng Guo,et al.  Il17A Autoantibody Induced by Recombinant Protein Ag85A-Il17A , 2012, Applied Biochemistry and Biotechnology.

[21]  I. Weissman,et al.  Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. , 2011, Blood.

[22]  R. Flavell,et al.  Vγ4 γδ T Cell-Derived IL-17A Negatively Regulates NKT Cell Function in Con A-Induced Fulminant Hepatitis , 2011, The Journal of Immunology.

[23]  Juan Li,et al.  Natural Killer-22 Cells in the Synovial Fluid of Patients with Rheumatoid Arthritis Are an Innate Source of Interleukin 22 and Tumor Necrosis Factor-α , 2011, The Journal of Rheumatology.

[24]  William E Louch,et al.  Methods in cardiomyocyte isolation, culture, and gene transfer. , 2011, Journal of molecular and cellular cardiology.

[25]  R. Wu,et al.  NF-κB mediates IL-1β- and IL-17A-induced MUC5B expression in airway epithelial cells. , 2011, American journal of respiratory cell and molecular biology.

[26]  M. Kimura,et al.  Mechanisms of IFNγ regulation of autoimmune myocarditis. , 2010, Experimental and molecular pathology.

[27]  Y. Iwakura,et al.  Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy , 2010, Circulation research.

[28]  Michael G Brown,et al.  Intrahepatic IL-10 Maintains NKG2A+Ly49− Liver NK Cells in a Functionally Hyporesponsive State , 2010, The Journal of Immunology.

[29]  M. Klapholz,et al.  Acute eosinophilic myocarditis: Diagnosis and treatment , 2010, Acute cardiac care.

[30]  S. Gasser,et al.  The role of natural killer cells in cancer therapy. , 2010, Frontiers in bioscience.

[31]  Miao Yang,et al.  Plasma IL-17A Is Increased in New-Onset SLE Patients and Associated with Disease Activity , 2010, Journal of Clinical Immunology.

[32]  P. Queirolo,et al.  Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[33]  R. Wu,et al.  Regulation of Airway MUC5AC Expression by IL-1β and IL-17A; the NF-κB Paradigm1 , 2009, The Journal of Immunology.

[34]  W. H. Wang,et al.  The polymorphisms of interleukin 17A (IL17A) gene and its association with pediatric asthma in Taiwanese population , 2009, Allergy.

[35]  N. Lévêque,et al.  Viral causes of human myocarditis. , 2009, Archives of cardiovascular diseases.

[36]  Y. Shoenfeld,et al.  NK cells in autoimmunity: a two-edg'd weapon of the immune system. , 2008, Autoimmunity reviews.

[37]  M. Kimura,et al.  Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. , 2008, The American journal of pathology.

[38]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[39]  N. Rose,et al.  Pathogenesis of myocarditis and dilated cardiomyopathy. , 2008, Advances in immunology.

[40]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[41]  David Voehringer,et al.  Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages , 2007, Journal of leukocyte biology.

[42]  H. Ljunggren,et al.  Prospects for the use of NK cells in immunotherapy of human cancer , 2007, Nature Reviews Immunology.

[43]  T. O’Connell,et al.  Isolation and culture of adult mouse cardiac myocytes. , 2007, Methods in molecular biology.

[44]  A. Ignaszewski,et al.  Eosinophilic myocarditis: case series and review of literature. , 2006, The Canadian journal of cardiology.

[45]  F. Luscinskas,et al.  Isolation and culture of murine heart and lung endothelial cells for in vitro model systems. , 2006, Methods in molecular biology.

[46]  N. Rose.  The significance of autoimmunity in myocarditis. , 2006, Ernst Schering Research Foundation workshop.

[47]  S Al-Haddad,et al.  The role of eosinophils in inflammatory bowel disease , 2005, Gut.

[48]  H. Hall,et al.  NK cells: elusive players in autoimmunity. , 2005, Trends in immunology.

[49]  Shaohua Chen,et al.  IFN-γ Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[50]  H. Virgin,et al.  Natural Killer Cells Utilize both Perforin and Gamma Interferon To Regulate Murine Cytomegalovirus Infection in the Spleen and Liver , 2005, Journal of Virology.

[51]  Shaohua Chen,et al.  IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis. , 2005, Journal of immunology.

[52]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[53]  J. Parrillo,et al.  Eosinophilic myocarditis. , 2005, Heart failure clinics.

[54]  N. Rose,et al.  Autoimmune myocarditis: cellular mediators of cardiac dysfunction. , 2004, Autoimmunity reviews.

[55]  A. di Lenarda,et al.  Fatal myocarditis: morphologic and clinical features. , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.

[56]  T. Yamamura,et al.  The regulatory role of natural killer cells in multiple sclerosis. , 2004, Brain : a journal of neurology.

[57]  Christophe Benoist,et al.  Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  D. Kass,et al.  Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. , 2004, The American journal of pathology.

[59]  Rajni B. Sharma,et al.  Animal models for autoimmune myocarditis and autoimmune thyroiditis. , 2004, Methods in molecular medicine.

[60]  T. Williams,et al.  CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 , 2003, European journal of immunology.

[61]  R. Moots,et al.  Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype. , 2003, Rheumatology.

[62]  N. Dalbeth,et al.  A subset of natural killer cells is greatly expanded within inflamed joints. , 2002, Arthritis and rheumatism.

[63]  S. Orkin,et al.  Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.

[64]  N. Rose,et al.  From infection to autoimmunity. , 2001, Journal of autoimmunity.

[65]  S. Akira,et al.  IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells1 , 2000, The Journal of Immunology.

[66]  F. Shi,et al.  Natural killer cells determine the outcome of B cell–mediated autoimmunity , 2000, Nature Immunology.

[67]  C. Hogaboam,et al.  Chemokines and asthma: redundancy of function or a coordinated effort? , 1999, The Journal of clinical investigation.

[68]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[69]  T. Tabira,et al.  Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells , 1997, The Journal of experimental medicine.

[70]  L. Lanier.  Activating and inhibitory NK cell receptors. , 1998, Advances in experimental medicine and biology.

[71]  M. Mattéi,et al.  Genetic control of diabetes progression. , 1997, Immunity.

[72]  H. Kunishige,et al.  Acute necrotizing eosinophilic myocarditis with giant cell infiltration after remission of idiopathic thrombocytopenic purpura. , 1997, Internal medicine.

[73]  R. Virmani,et al.  Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[74]  M. Seminario,et al.  The role of eosinophils in the pathogenesis of asthma. , 1994, Current opinion in immunology.

[75]  C. Panagiotopoulos,et al.  Rheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor. , 1992, The Journal of rheumatology.

[76]  J. Narula,et al.  Asymptomatic eosinophilic myocarditis: 2 + 2 = 4 or 5! , 1991, International journal of cardiology.

[77]  T. Suzuki,et al.  Idiopathic myocarditis associated with T-cell subset changes and depressed natural killer activity. , 1990, Japanese heart journal.

[78]  B. McManus,et al.  Phenotypic analysis of infiltrating cells in human myocarditis. An immunohistochemical study in paraffin-embedded tissue. , 1989, Archives of pathology & laboratory medicine.

[79]  Yang Yz,et al.  Natural killer cell activity and induction of alpha and gamma interferon in patients with Coxsackie B viral myocarditis , 1988 .

[80]  K. Beisel,et al.  Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. , 1987, Journal of immunology.

[81]  C. Gauntt,et al.  Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. , 1986, Journal of immunology.

[82]  N. Tamaoki,et al.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. , 1981, Journal of immunology.

[83]  T. Yoneda,et al.  In vivo effect of anti-asialo GM1 antibody on natural killer activity , 1981, Nature.